News

A newly published article offers advice to help scientists who study obesity, diabetes or other metabolic diseases better account for inherent sex differences in research.

Elesevier release new version of Reaxys Medicinal Chemistry to improve the discoverability and extraction of relevant chemistry data

A small team of scientists from China’s Heibei University has developed an LC-MS/MS method for assessing blood plasma concentrations of an antioxidant isolated from paeonies.

Novartis-backed research finds pyrazolopyridine drug combats Cryptosporidium and shows promise in clinical models of pediatric diarrhoea, which is responisble for 8.6% of global child mortality.

High throughput screening method enables researchers to successfully engineer E. coli to manufacture plant Cytochrome P450s.

Combo of T-cell therapy, newly FDA-approved drug and another immunotherapeutic agent kept cancer at bay for three out of four patients with metastatic Merkel cell carcinoma.

Acquisition broadens Lonza’s manufacturing capabilities in Europe

Research in the field of kidney cancer, also called renal cancer, is vital, because many patients with this disease still cannot be cured today.

As CRISPR-Cas9 starts to move into clinical trials, a new study has found that the gene-editing technology can introduce hundreds of unintended mutations into the genome.

A team from the University of Wisconsin School of Medicine and public Health and the Wisconsin National Primate Research Center have coaxed stem cells to become the cells that make up human veins, arteries and capillaries.